Home / Feed item / OIRM: Safety shown in multi-centre phase II clinical trial for using #stemcells in cardiomyopathy patients http://www.ncbi.nlm.nih.gov/pubmed/27665225 #PubMedCrawl
OIRM: Safety shown in multi-centre phase II clinical trial for using #stemcells in cardiomyopathy patients http://www.ncbi.nlm.nih.gov/pubmed/27665225 #PubMedCrawl
Our Vision
OIRM will transform the treatment of incurable diseases, making Ontario a global leader in the development and dissemination and dissemination of stem cell-based products and therapies.
